Drug Database
Back to search

United States· US:85477-101_440d6c53-6c13-3f8d-e063-6294a90a2a2b

Methocarbamol

A methocarbamol product containing methocarbamol, registered in United States by Oncora Pharma, LLC. The same ATC class is registered in 12 of our 19 countries.

ATC M03BA03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMethocarbamolATCM03BA03REGISTER NO.US:85477-101_440d6c53…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methocarbamolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methocarbamol is registered in 12 of 19 countries.

Countries holding a registration under ATC M03BA03 (methocarbamol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose
Search methocarbamol products by name

Methocarbamol · ATC M03BA03

12 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methocarbamol costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

  • United States: $0.17 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Methocarbamol · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • US United States$0.17 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHOCARBAMOL
Manufacturer
Oncora Pharma, LLC
Country
United States (US)
ATC code
M03BA03
ATC class
Methocarbamol
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    85477-101-10
  • ndc11
    8547710110
    100 TABLET, COATED in 1 BOTTLE, PLASTIC (85477-101-10)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

169 interactions on record for methocarbamol.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methocarbamol against other medicinesHow interaction checks work

Methocarbamol · interactions on record

169 records

  • 4 severe
  • 53 moderate
  • 112 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methocarbamol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methocarbamol products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Methocarbamol Kwizda
  • Czechia · Dolirobax
  • Germany · Methoca, Methocarbamol Al
  • Spain · Dolirobax, Molitrem
  • France · Lumirelax, Methocarbamol Arrow
  • United Kingdom (Northern Ireland) · Methocarbamol Activase Pharmaceuticals, Methocarbamol Amarox
  • Hungary · Dolirobax Tabletta
  • Luxembourg · Methocarbamol Micro Labs
  • Malta · Rolaxifor
  • Poland · Methocarbamol Espefa
  • Portugal · Robaxisal, Zelaz
  • Slovakia · Dolirobax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d70c141b-605f-4e54-a5e1-3cea981b6cc1
GET /v1/drugs/d70c141b-605f-4e54-a5e1-3cea981b6cc1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "1000",
  "substance": "METHOCARBAMOL",
  "productndc": "85477-101",
  "dosage_form": "TABLET, COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA200958",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about methocarbamol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console